According to The Insight Partners' research, the Europe Connected Health Market was valued at US$ 23,394.3 Million in 2024 and is expected to reach US$ 123,323.1 Million by 2031, registering a CAGR of 27.0% from 2025 to 2031.
Cross-industry collaborations and advancements in medical technology among the critical factors attributed to driving the Europe connected health market growth.
The connected healthcare market is witnessing a transformative phase, driven largely by the integration of digital technologies such as IoT, AI, and big data analytics with traditional healthcare services. One of the most promising opportunities in this space lies in the increasing trend of cross-industry collaborations. By bridging the gap between healthcare providers, technology companies, pharmaceutical firms, and even sectors like telecommunications and consumer electronics, these partnerships foster innovation, improve patient outcomes, and create scalable, efficient healthcare solutions. Cross-industry collaborations bring together diverse expertise and resources that can accelerate the development and deployment of connected healthcare technologies. For instance, technology giants like Google and Apple have partnered with healthcare organizations to develop health tracking and telemedicine platforms that leverage their vast data processing and user-interface capabilities. These collaborations not only enable advanced remote patient monitoring but also enhance data sharing across platforms while maintaining privacy and security, a crucial factor in healthcare. The European Union has been fostering cross-border collaboration through initiatives like the European Health Data Space (EHDS), which aims to enable secure and trustworthy accessibility to health data across the EU. The EHDS regulation, adopted in 2025, focuses on ensuring individuals have access to and control over their health data in the context of healthcare, establishing a single market for digital health, and allowing researchers, innovators, policymakers, and regulators to make the most of available health data for societal benefit. This regulation facilitates collaboration among EU member states and stakeholders to create a unified digital health ecosystem.
Moreover, collaborations between telecom companies and healthcare providers have played a vital role in expanding the reach of connected healthcare, especially in rural and underserved regions.
These collaborations exemplify how converging capabilities across industries can create robust ecosystems that support not only the growth of connected healthcare but also a shift towards preventive and personalized medicine. By combining domain-specific knowledge and cutting-edge technology, cross-industry partnerships are poised to redefine healthcare delivery and create lasting opportunities for innovation and market expansion.
On the contrary, the concern over data privacy and security hampers the growth of the Europe connected health market.
Europe Connected Health Market Segmentation Analysis:
- By Product Type, the Europe Connected Health Market is segmented into M-Health Devices and M-Health Services. The M-Health Devices segment is projected to expand at 26.6% CAGR during 2025 - 2031.
- By Application, the Europe Connected Health Market is segmented into Monitoring Application, Diagnostic and Treatment, Healthcare Management, Wellness and Prevention, and Others. The Monitoring Application segment is projected to expand at 27.2% CAGR during 2025 - 2031.
- By End User, the Europe Connected Health Market is segmented into Hospitals and Clinics, Home Monitoring, and Others. The Hospitals and Clinics segment is projected to expand at 27.4% CAGR during 2025 - 2031.
By country, the Europe Connected Health Market is categorized into Germany, the United Kingdom, France, Italy, Spain, and the Rest of Europe. Germany is projected to expand at 27.2% CAGR during 2025 - 2031.
Key players operating in the Connected Health Market are International Business Machines Corp, OMRON Corp, Abbott Laboratories, Boston Scientific Corp, Medtronic Plc, Koninklijke Philips NV, GE HealthCare Technologies Inc, Apple Inc, Fitbit LLC, and Samsung Electronics Co Ltd, among others.
- In July 2025, Drager, Hamilton Medical, Getinge and leading infusion pump company B.Braun Melsungen AG -to drive operational improvements and enhance the hospital experience for both patients and clinicians. These partnerships are centered around Service-Oriented Device Connectivity (SDC) standards, which will enable interoperability across medical devices and platforms. SDC supports a common language between SDC-certified medical devices, so clinicians can easily see and act upon data derived from these technologies, regardless of the device manufacturer.
- In July 2025, Philips received FDA clearance for its SmartSpeed Precise Dual AI Software for MRI, indicating their continued investment in AI-powered imaging, which relies on the collection and analysis of data, a core aspect of IoT in medical devices.
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com